Manager of Regulatory Affairs, EMEA, Thermo Fisher Scientific
BIOGRAPHY
JAN 25, 2022 10:00 AM CET
IVDR transition -- impact and opportunities for a molecular pathology laboratory
Presented at:
Lab Compliance Connect
Speakers
-
Johanna Koolen
Senior Regulatory Analyst, Thermo Fisher ScientificBIOGRAPHY
Abstract
In this webinar, you’ll learn about the value of the new in vitro diagnostic regulation (IVDR) and its impact on molecular pathology laboratories, biotechnology and pharma industries, as well as its benefit to the future of precision medicine.
Learning objectives:
• Explain the differences between in vitro diagnostic directive (IVDD) and IVDR, and the benefits of the new regulation
• Identify the IVDR challenges and bottlenecks that industries are facing and ways to mitigate them
• Discuss the IVDR impact on laboratory-developed tests (LDTs) and implications for molecular pathology laboratories and patients
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...